Noticias corporativas

Farma Mondo Group and Stemline Therapeutics B.V. sign exclusive partnership to grant access to Elacestrant through Named Patient Supplies to patients in certain Countries where the product is not licensed or not commercially available.

Chiasso, Switzerland and Ashburn, US – 28th July, 2023 – Farma Mondo Group, a Swiss-based pharmaceutical group focused on providing market access and speciality distribution services through a unique infrastructure and geographical footprint across emerging and emerged markets, announces today the signing of a licensing and distribution agreement with Quoin Pharmaceuticals Inc. for exclusive rights to commercialize QRX003 in Singapore.

CHIASSO, Switzerland and SINGAPORE – February 6th, 2023 – Farma Mondo Group, a Swiss-based pharmaceutical group focused on providing market access and speciality distribution services through

CHIASSO, Switzerland and LUGANO, Switzerland – November 28, 2022 – Farma Mondo Group, a Swiss-based pharmaceutical group focused on providing market access and speciality distribution